TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 78 filers reported holding TRICIDA INC in Q4 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,904,000 | +289.3% | 277,089 | +259.6% | 0.02% | +283.3% |
| Q2 2022 | $746,000 | -78.4% | 77,051 | -81.6% | 0.01% | -73.9% |
| Q1 2022 | $3,449,000 | -13.4% | 419,605 | +0.7% | 0.02% | -14.8% |
| Q4 2021 | $3,982,000 | +56.6% | 416,483 | -24.0% | 0.03% | +58.8% |
| Q3 2021 | $2,543,000 | -30.1% | 548,120 | -34.9% | 0.02% | -32.0% |
| Q2 2021 | $3,638,000 | -0.5% | 842,126 | +21.8% | 0.02% | -10.7% |
| Q1 2021 | $3,657,000 | +149.5% | 691,251 | +232.5% | 0.03% | +115.4% |
| Q4 2020 | $1,466,000 | -24.8% | 207,898 | -3.4% | 0.01% | -35.0% |
| Q3 2020 | $1,949,000 | -61.5% | 215,175 | +16.9% | 0.02% | -63.6% |
| Q2 2020 | $5,059,000 | – | 184,087 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |